AUTL — Autolus Therapeutics plc stock price, charts and financials

QT53Autolus Therapeutics plc

Autolus Therapeutics plc (NASDAQ: AUTL) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
1.95
+0.13+7.14%
OverviewShort InterestFilings
AUTLQT53Autolus Therapeutics plc·NASDAQ
1.95+7.14%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 03, 20268-KCurrent report
Aug 03, 20268-KCurrent report
Jul 01, 20264Statement of changes in beneficial ownership
Jul 01, 20264Statement of changes in beneficial ownership
Jul 01, 20264Statement of changes in beneficial ownership
Jul 01, 20264Statement of changes in beneficial ownership
Jul 01, 20264Statement of changes in beneficial ownership
Jul 01, 20264Statement of changes in beneficial ownership
Jul 01, 20264Statement of changes in beneficial ownership
Jul 01, 20264Statement of changes in beneficial ownership
Jul 01, 20264Statement of changes in beneficial ownership
Jun 29, 20268-KCurrent report
Jun 09, 20268-KCurrent report
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 14, 202610-QQuarterly report
May 14, 20268-KCurrent report
May 05, 2026EFFECTNotice of effectiveness
May 05, 2026EFFECTNotice of effectiveness
Apr 29, 20268-KCurrent report
Apr 16, 20268-KCurrent report
Apr 15, 2026DEL AMDEL AM
Apr 15, 2026DEL AMDEL AM
Apr 13, 2026S-3Shelf registration statement
Apr 13, 2026S-3Shelf registration statement
#1 / 25 of 206
Page
▼
/ 9